Greg Conko on FDA Approval for Avastin

CEI Senior Fellow Greg Conko discusses the FDA's pending decision on whether or not to withdraw its approval of Avastin as a treatment for breast cancer. Greg argues that because it is effective for a small proportion of breast cancer patients, they should be able to decide for themselves if they want to use it.